StockVS

MetLife, Inc. (MET) Stock Analysis

Financial Services

MetLife, Inc.

$83.27

$-0.79 (-0.94%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Company Overview

MetLife, Inc. operates as a global financial services entity that delivers comprehensive insurance products, annuities, employee benefits, and asset management services across various international markets. The organization functions within the Financial Services sector, specifically targeting the Insurance - Life industry, which focuses on providing long-term protection and retirement planning solutions to individuals and corporations. The company demonstrates significant scale with a total market capitalization of $44.61B and an annual revenue stream of $77.08B, supported by a workforce of 46000 employees. These valuation and revenue figures indicate that MetLife maintains a substantial position within the life insurance industry, reflecting its extensive reach and operational capacity to manage vast pools of assets and liabilities worldwide.

Financial Health

The company reported a total revenue of $77.08B over the trailing twelve months, generating $3.17B in net income and $5.96B in EBITDA. The substantial gap between the $77.08B revenue and the $3.17B net income reveals a cost structure heavily influenced by the inherent leverage of the insurance business model, where high premiums are required to cover claims and operating expenses before reaching profitability. However, the free cash flow stands at -$12,738,499,584, which indicates a temporary outflow of cash likely driven by the timing of asset acquisitions or liability payments typical for insurers, suggesting limited immediate financial flexibility for aggressive capital expansion. Despite this cash outflow, the balance sheet holds $25.63B in cash against $65.35B in total debt, resulting in a debt-to-equity ratio of 225.97, which characterizes the balance sheet as highly leveraged given the asset-intensive nature of the insurance industry. Liquidity management is supported by a current ratio of 1.90, indicating that the company holds sufficient current assets to cover its short-term liabilities nearly twice over. Return metrics show a Return on Equity of 12.0% and a Return on Assets of 0.5%, where the high ROE suggests effective generation of profit relative to shareholder equity, while the low ROA reflects the capital-intensive structure where total assets are significantly larger than equity.

Valuation Assessment

Valuation multiples reveal a Trailing Twelve Months P/E ratio of 14.37 compared to a Forward P/E of 6.19. The significant difference between these two metrics implies that the market expects a substantial rebound in earnings in the coming year, as the forward multiple is priced on much lower expected earnings relative to the current stock price. The Price to Book ratio stands at 1.56, indicating that the market values the company at a premium of 56% above its book value, which suggests investors are willing to pay more than the net asset value. Alternative valuation metrics include a Price to Sales ratio of 0.58 and an EV/EBITDA of 14.15, which suggest the company is trading at a discount relative to its sales but commands a premium when adjusted for enterprise value and operating earnings. The stock has traded between a 52-week low of $65.21 and a 52-week high of $85.00, and while the exact current price is not provided in the facts, the forward P/E implies a valuation near the lower end of the historical trading range relative to the 52-week high. The Beta of 0.74 indicates that the stock exhibits lower price volatility relative to the broader market, moving less dramatically than the overall index during periods of market fluctuation.

Growth & Income

Growth metrics display a Revenue Growth of 27.6% year-over-year contrasted with an Earnings Growth of -34.2% year-over-year. The fact that earnings are declining significantly faster than revenue implies that one-time charges, investment losses, or increased cost of goods sold have temporarily compressed profitability despite strong top-line expansion. As a dividend payer, the company offers a Dividend Yield of 3.4% with a Payout Ratio of 47.7%, indicating that the payout is funded from earnings rather than cash reserves, though the negative earnings growth warrants monitoring of sustainability. The high payout ratio combined with negative earnings growth suggests the dividend may be under pressure as profitability recovers, requiring careful observation of how the company manages this obligation relative to its financial constraints. The overall growth and income profile presents a scenario of robust revenue expansion offset by sharp earnings contraction, supported by a moderate yield that reflects the market's caution regarding the temporary dip in profitability.

Peer Comparison

MetLife, Inc. (MET) operates in the Insurance - Life industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
MetLife, Inc. MET $53.58B 16.1
Manulife Financial Corporation MFC.TO $88.82B 15.3
Great-West Lifeco Inc. GWO.TO $71.39B 17.1
Manulife Financial Corporation MFC $64.39B 15.3

The Insurance - Life industry average P/E ratio is 18.3x. MetLife, Inc. trades at a P/E of 16.1.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Visit website →

Key Statistics

Market Cap
$53.58B
P/E Ratio
16.11
52-Week High
$85.29
52-Week Low
$67.33
Avg Volume
3.58M
Beta
0.78
Dividend Yield
2.85%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
46,000